The effects of bariatric surgery on bone and nephrolithiasis

Bone

Volumn 84, Issue , 2016, Pages 1-8

  Sakhaee, Khashayar ^a   Poindexter, John ^a   Aguirre, Crystal ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Bariatric surgery; Bone disease; Kidney stone disease

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; GASTROINTESTINAL POLYPEPTIDE; OXALIC ACID;

BARIATRIC SURGERY; BIOMECHANICS; BONE DENSITY; BONE DISEASE; BONE METABOLISM; BONE STRENGTH; BONE STRESS; BONE STRUCTURE; CALCIUM ABSORPTION; CALCIUM URINE LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; DISEASE ASSOCIATION; DISEASE COURSE; FRAGILITY FRACTURE; GASTRIC BANDING; HIP DISEASE; HORMONE METABOLISM; HUMAN; HYPOCITRATURIA; INCIDENCE; LONGITUDINAL STUDY; METABOLIC DISORDER; MINERAL METABOLISM; NEPHROLITHIASIS; NONHUMAN; OSTEOMALACIA; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; SENILE OSTEOPOROSIS; SLEEVE GASTRECTOMY; SPINE DISEASE; STOMACH ACID SECRETION; STOMACH BYPASS; SURGICAL TECHNIQUE; TREATMENT RESPONSE; URINE PH; URINE VOLUME; WEIGHT REDUCTION; ADVERSE EFFECTS; BONE; FRACTURES, BONE; OSTEOLYSIS; PATHOLOGY;

BARIATRIC SURGERY; BONE AND BONES; BONE DENSITY; BONE RESORPTION; FRACTURES, BONE; HUMANS; NEPHROLITHIASIS;

EID: 84954089544     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2015.12.001     Document Type: Review

References (78)

1. Flegal K.M., Carroll M.D., Kit B.K., Ogden C.L. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012, 307(5):491-497. 10.1001/jama.2012.39.
2. Ogden C.L., Carroll M.D., Kit B.K., Flegal K.M. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014, 311(8):806-814. 10.1001/jama.2014.732.
3. Arterburn D.E., Olsen M.K., Smith V.A., et al. Association between bariatric surgery and long-term survival. JAMA 2015, 313(1):62-70. 10.1001/jama.2014.16968.
4. Chang S.H., Stoll C.R., Song J., Varela J.E., Eagon C.J., Colditz G.A. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg. 2014, 149(3):275-287. 10.1001/jamasurg.2013.3654.
5. Reames B.N., Finks J.F., Bacal D., Carlin A.M., Dimick J.B. Changes in bariatric surgery procedure use in Michigan, 2006-2013. JAMA 2014, 312(9):959-961. 10.1001/jama.2014.7651.
6. Lalmohamed A., de Vries F., Bazelier M.T., et al. Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study. BMJ 2012, 345(e5085). 10.1136/bmj.e5085.
7. Nakamura K.M., Haglind E.G., Clowes J.A., et al. Fracture risk following bariatric surgery: a population-based study. Osteoporos. Int. 2014, 25(1):151-158. 10.1007/s00198-013-2463-x.
8. Ikramuddin S., Billington C.J., Lee W.J., et al. Roux-En-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial. Lancet Diab. Endocrinol. 2015, 3(6):413-422. 10.1016/S2213-8587(15)00089-3.
9. Goldner W.S., O'Dorisio T.M., Dillon J.S., Mason E.E. Severe metabolic bone disease as a long-term complication of obesity surgery. Obes. Surg. 2002, 12(5):685-692. 10.1381/096089202321019693.
10. von Mach M.A., Stoeckli R., Bilz S., Kraenzlin M., Langer I., Keller U. Changes in bone mineral content after surgical treatment of morbid obesity. Metabolism 2004, 53(7):918-921. 10.1016/j.metabol.2004.01.015.
11. Carrasco F., Ruz M., Rojas P., et al. Changes in bone mineral density, body composition and adiponectin levels in morbidly obese patients after bariatric surgery. Obes. Surg. 2009, 19(1):41-46. 10.1007/s11695-008-9638-0.
12. Casagrande D.S., Repetto G., Mottin C.C., et al. Changes in bone mineral density in women following 1-year gastric bypass surgery. Obes. Surg. 2012, 22(8):1287-1292. 10.1007/s11695-012-0687-z.
13. Nogues X., Goday A., Pena M.J., et al. Bone mass loss after sleeve gastrectomy: a prospective comparative study with gastric bypass. Cir. Esp. 2010, 88(2):103-109. 10.1016/j.ciresp.2010.04.008.
14. Johnson J.M., Maher J.W., Samuel I., Heitshusen D., Doherty C., Downs R.W. Effects of gastric bypass procedures on bone mineral density, calcium, parathyroid hormone, and vitamin D. J. Gastrointest. Surg. 2005, 9(8):1106-1110. 10.1016/j.gassur.2005.07.012.
15. Coates P.S., Fernstrom J.D., Fernstrom M.H., Schauer P.R., Greenspan S.L. Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J. Clin. Endocrinol. Metab. 2004, 89(3):1061-1065. 10.1210/jc.2003-031756.
16. Yu E.W., Bouxsein M.L., Roy A.E., et al. Bone loss after bariatric surgery: discordant results between DXA and QCT bone density. J. Bone Miner. Res. 2014, 29(3):542-550. 10.1002/jbmr.2063.
17. Vilarrasa N., San Jose P., Garcia I., et al. Evaluation of bone mineral density loss in morbidly obese women after gastric bypass: 3-year follow-up. Obes. Surg. 2011, 21(4):465-472. 10.1007/s11695-010-0338-1.
18. Fleischer J., Stein E.M., Bessler M., et al. The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss. J. Clin. Endocrinol. Metab. 2008, 93(10):3735-3740. 10.1210/jc.2008-0481.
19. Carlin A.M., Rao D.S., Yager K.M., Parikh N.J., Kapke A. Treatment of vitamin D depletion after Roux-en-Y gastric bypass: a randomized prospective clinical trial. Surg. Obes. Relat. Dis. 2009, 5(4):444-449. 10.1016/j.soard.2008.08.004.
20. Stein E.M., Carrelli A., Young P., et al. Bariatric surgery results in cortical bone loss. J. Clin. Endocrinol. Metab. 2013, 98(2):541-549. 10.1210/jc.2012-2394.
21. Vilarrasa N., Gomez J.M., Elio I., et al. Evaluation of bone disease in morbidly obese women after gastric bypass and risk factors implicated in bone loss. Obes. Surg. 2009, 19(7):860-866. 10.1007/s11695-009-9843-5.
22. Pluskiewicz W., Buzga M., Holeczy P., Bortlik L., Smajstrla V., Adamczyk P. Bone mineral changes in spine and proximal femur in individual obese women after laparoscopic sleeve gastrectomy: a short-term study. Obes. Surg. 2012, 22(7):1068-1076. 10.1007/s11695-012-0654-8.
23. Ruiz-Tovar J., Oller I., Priego P., et al. Short- and mid-term changes in bone mineral density after laparoscopic sleeve gastrectomy. Obes. Surg. 2013, 23(7):861-866. 10.1007/s11695-013-0866-6.
24. Yu E.W., Bouxsein M.L., Putman M.S., et al. Two-year changes in bone density after Roux-en-Y gastric bypass surgery. J. Clin. Endocrinol. Metab. 2015, 100(4):1452-1459. 10.1210/jc.2014-4341.
25. Nguyen N.T., Nguyen B., Gebhart A., Hohmann S. Changes in the makeup of bariatric surgery: a national increase in use of laparoscopic sleeve gastrectomy. J. Am. Coll. Surg. 2013, 216(2):252-257. 10.1016/j.jamcollsurg.2012.10.003.
26. Lazzati A., Guy-Lachuer R., Delaunay V., Szwarcensztein K., Azoulay D. Bariatric surgery trends in France: 2005-2011. Surg. Obes. Relat. Dis. 2014, 10(2):328-334. 10.1016/j.soard.2013.07.015.
27. Schoenau E., Frost H.M. The "muscle-bone unit" in children and adolescents. Calcif. Tissue Int. 2002, 70(5):405-407. 10.1007/s00223-001-0048-8.
28. Lin C., Jiang X., Dai Z., et al. Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling. J. Bone Miner. Res. 2009, 24(10):1651-1661. 10.1359/jbmr.090411.
29. Li X., Ominsky M.S., Warmington K.S., et al. Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis. J. Bone Miner. Res. 2009, 24(4):578-588. 10.1359/jbmr.081206.
30. Wijenayaka A.R., Kogawa M., Lim H.P., Bonewald L.F., Findlay D.M., Atkins G.J. Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway. PLoS ONE 2011, 6(10). 10.1371/journal.pone.0025900.
31. Muschitz C., Kocijan R., Marterer C., et al. Sclerostin levels and changes in bone metabolism after bariatric surgery. J. Clin. Endocrinol. Metab. 2015, 100(3):891-901. 10.1210/jc.2014-3367.
32. Schafer A.L., Weaver C.M., Black D.M., et al. Intestinal calcium absorption decreases dramatically after gastric bypass surgery despite optimization of vitamin D status. J. Bone Miner. Res. 2015, 10.1002/jbmr.2467.
33. Pak C.Y., Poindexter J., Finlayson B. A model system for assessing physicochemical factors affecting calcium absorbability from the intestinal tract. J. Bone Miner. Res. 1989, 4(1):119-127. 10.1002/jbmr.5650040117.
34. Stemmer K., Bielohuby M., Grayson B.E., et al. Roux-en-Y gastric bypass surgery but not vertical sleeve gastrectomy decreases bone mass in male rats. Endocrinology 2013, 154(6):2015-2024. 10.1210/en.2012-2130.
35. Hey H., Stokholm K.H., Lund B., Lund B., Sorensen O.H. Vitamin D deficiency in obese patients and changes in circulating vitamin D metabolites following jejunoileal bypass. Int. J. Obes. 1982, 6(5):473-479.
36. Sakhaee K. Bariatric surgery and effects on calcium and bone metabolism. Clin. Rev. Bone Miner. Metab. 2014, 12(4):240-251. 10.1007/s12018-013-9145-2.
37. Ott M.T., Fanti P., Malluche H.H., et al. Biochemical evidence of metabolic bone disease in women following Roux-Y gastric bypass for morbid obesity. Obes. Surg. 1992, 2(4):341-348.
38. Heber D., Greenway F.L., Kaplan L.M., et al. Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2010, 95(11):4823-4843. 10.1210/jc.2009-2128.
39. Slater G.H., Ren C.J., Siegel N., et al. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J. Gastrointest. Surg. 2004, 8(1):48-55.
40. Fuleihan Gel H., Bouillon R., Clarke B., et al. Serum 25-hydroxyvitamin D levels: variability, knowledge gaps, and the concept of a desirable range. J. Bone Miner. Res. 2015, 30(7):1119-1133. 10.1002/jbmr.2536.
41. Dawson-Hughes B., Heaney R.P., Holick M.F., Lips P., Meunier P.J., Vieth R. Estimates of optimal vitamin D status. Osteoporos. Int. 2005, 16(7):713-716. 10.1007/s00198-005-1867-7.
42. Institute of Medicine Committee to Review Dietary Reference Intakes for Vitamin D, Calcium The National Academies Collection: reports funded by National Institutes of Health. Dietary Reference Intakes for Calcium and Vitamin D 2011, National Academies Press (US), National Academy of Sciences, Washington (DC). A.C. Ross, C.L. Taylor, A.L. Yaktine, H.B. Del Valle (Eds.).
43. Cummings D.E., Weigle D.S., Frayo R.S., et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N. Engl. J. Med. 2002, 346(21):1623-1630. 10.1056/NEJMoa012908.
44. Pournaras D.J., le Roux C.W. Ghrelin and metabolic surgery. Int J Pept. 2010, 2010. 10.1155/2010/217267.
45. Karamanakos S.N., Vagenas K., Kalfarentzos F., Alexandrides T.K. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-Yy levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann. Surg. 2008, 247(3):401-407. 10.1097/SLA.0b013e318156f012.
46. Maccarinelli G., Sibilia V., Torsello A., et al. Ghrelin regulates proliferation and differentiation of osteoblastic cells. J. Endocrinol. 2005, 184(1):249-256. 10.1677/joe.1.05837.
47. Napoli N., Pedone C., Pozzilli P., et al. Effect of ghrelin on bone mass density: the InChianti study. Bone 2011, 49(2):257-263. 10.1016/j.bone.2011.03.772.
48. Bollag R.J., Zhong Q., Phillips P., et al. Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors. Endocrinology 2000, 141(3):1228-1235. 10.1210/endo.141.3.7366.
49. Nuche-Berenguer B., Moreno P., Esbrit P., et al. Effect of Glp-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states. Calcif. Tissue Int. 2009, 84(6):453-461. 10.1007/s00223-009-9220-3.
50. Matlaga B.R., Shore A.D., Magnuson T., Clark J.M., Johns R., Makary M.A. Effect of gastric bypass surgery on kidney stone disease. J. Urol. 2009, 181(6):2573-2577. 10.1016/j.juro.2009.02.029.
51. Lieske J.C., Mehta R.A., Milliner D.S., Rule A.D., Bergstralh E.J., Sarr M.G. Kidney stones are common after bariatric surgery. Kidney Int. 2015, 87(4):839-845. 10.1038/ki.2014.352.
52. Semins M.J., Matlaga B.R., Shore A.D., et al. The effect of gastric banding on kidney stone disease. Urology 2009, 74(4):746-749. 10.1016/j.urology.2009.04.093.
53. Chen T., Godebu E., Horgan S., Mirheydar H.S., Sur R.L. The effect of restrictive bariatric surgery on urolithiasis. J. Endourol. 2013, 27(2):242-244. 10.1089/end.2012.0408.
54. Sinha M.K., Collazo-Clavell M.L., Rule A., et al. Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int. 2007, 72(1):100-107. 10.1038/sj.ki.5002194.
55. Asplin J.R., Coe F.L. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J. Urol. 2007, 177(2):565-569. 10.1016/j.juro.2006.09.033.
56. Park A.M., Storm D.W., Fulmer B.R., Still C.D., Wood G.C., Hartle J.E. A prospective study of risk factors for nephrolithiasis after Roux-En-Y gastric bypass surgery. J. Urol. 2009, 182(5):2334-2339. 10.1016/j.juro.2009.07.044.
57. Duffey B.G., Pedro R.N., Makhlouf A., et al. Roux-en-Y gastric bypass is associated with early increased risk factors for development of calcium oxalate nephrolithiasis. J. Am. Coll. Surg. 2008, 206(3):1145-1153. 10.1016/j.jamcollsurg.2008.01.015.
58. Duffey B.G., Alanee S., Pedro R.N., et al. Hyperoxaluria is a long-term consequence of Roux-en-Y gastric bypass: a 2-year prospective longitudinal study. J. Am. Coll. Surg. 2010, 211(1):8-15. 10.1016/j.jamcollsurg.2010.03.007.
59. Patel B.N., Passman C.M., Fernandez A., et al. Prevalence of hyperoxaluria after bariatric surgery. J. Urol. 2009, 181(1):161-166. 10.1016/j.juro.2008.09.028.
60. Sakhaee K. Recent advances in the pathophysiology of nephrolithiasis. Kidney Int. 2009, 75(6):585-595. 10.1038/ki.2008.626.
61. Kumar R., Lieske J.C., Collazo-Clavell M.L., et al. Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery. Surgery 2011, 149(5):654-661. 10.1016/j.surg.2010.11.015.
62. Froeder L., Arasaki C.H., Malheiros C.A., Baxmann A.C., Heilberg I.P. Response to dietary oxalate after bariatric surgery. Clin. J. Am. Soc. Nephrol. 2012, 7(12):2033-2040. 10.2215/CJN.02560312.
63. Kaufman D.W., Kelly J.P., Curhan G.C., et al. Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J. Am. Soc. Nephrol. 2008, 19(6):1197-1203. 10.1681/ASN.2007101058.
64. Dobbins J.W., Binder H.J. Effect of bile salts and fatty acids on the colonic absorption of oxalate. Gastroenterology 1976, 70(6):1096-1100. (http://dx.doi.org/S0016508576001376 [pii]).
65. Penniston K.L., Kaplon D.M., Gould J.C., Nakada S.Y. Gastric band placement for obesity is not associated with increased urinary risk of urolithiasis compared to bypass. J. Urol. 2009, 182(5):2340-2346. 10.1016/j.juro.2009.07.041.
66. Semins M.J., Asplin J.R., Steele K., et al. The effect of restrictive bariatric surgery on urinary stone risk factors. Urology 2010, 76(4):826-829. 10.1016/j.urology.2010.01.037.
67. Alpern R.J., Sakhaee K. The clinical spectrum of chronic metabolic acidosis: homeostatic mechanisms produce significant morbidity. Am. J. Kidney Dis. 1997, 29(2):291-302.
68. Kok D.J., Papapoulos S.E., Bijvoet O.L. Excessive crystal agglomeration with low citrate excretion in recurrent stone-formers. Lancet 1986, 1(8489):1056-1058.
69. Sakhaee K., Maalouf N.M., Sinnott B. Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management. J. Clin. Endocrinol. Metab. 2012, 97(6):1847-1860. 10.1210/jc.2011-3492.
70. Riedt C.S., Brolin R.E., Sherrell R.M., Field M.P., Shapses S.A. True fractional calcium absorption is decreased after Roux-en-Y gastric bypass surgery. Obesity (Silver Spring) 2006, 14(11):1940-1948. 10.1038/oby.2006.226.
71. Mechanick J.I., Kushner R.F., Sugerman H.J., et al. American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Surg. Obes. Relat. Dis. 2008, 4(5 Suppl.):S109-S184. 10.1016/j.soard.2008.08.009.
72. Heller H.J., Greer L.G., Haynes S.D., Poindexter J.R., Pak C.Y. Pharmacokinetic and pharmacodynamic comparison of two calcium supplements in postmenopausal women. J. Clin. Pharmacol. 2000, 40(11):1237-1244.
73. Tondapu P., Provost D., Adams-Huet B., Sims T., Chang C., Sakhaee K. Comparison of the absorption of calcium carbonate and calcium citrate after Roux-en-Y gastric bypass. Obes. Surg. 2009, 19(9):1256-1261. 10.1007/s11695-009-9850-6.
74. Sakhaee K., Pak C. Superior calcium bioavailability of effervescent potassium calcium citrate over tablet formulation of calcium citrate after Roux-en-Y gastric bypass. Surg. Obes. Relat. Dis. 2013, 9(5):743-748. 10.1016/j.soard.2011.11.011.
75. Sakhaee K., Griffith C., Pak C.Y. Biochemical control of bone loss and stone-forming propensity by potassium-calcium citrate after bariatric surgery. Surg. Obes. Relat. Dis. 2012, 8(1):67-72. 10.1016/j.soard.2011.05.001.
76. Suzuki Y., Ishibashi Y., Omura N., et al. Alendronate improves vitamin D-resistant osteopenia triggered by gastrectomy in patients with gastric cancer followed long term. J. Gastrointest. Surg. 2005, 9(7):955-960. 10.1016/j.gassur.2005.04.020.
77. Suzuki Y., Fukushima S., Iwai T., et al. Bisphosphonate incadronate prevents total gastrectomy-induced osteopenia in rats. Bone 2004, 35(6):1346-1352. 10.1016/j.bone.2004.09.006.
78. Rosen C.J., Brown S. Severe hypocalcemia after intravenous bisphosphonate therapy in occult vitamin D deficiency. N. Engl. J. Med. 2003, 348(15):1503-1504. 10.1056/NEJM200304103481521.